神經血管和神經系統醫療設備市場：按產品、適應症、技術、病患年齡層和最終用戶分類－2026-2032年全球市場預測

預計到 2032 年，神經血管和神經醫療設備市場規模將成長至 66.5 億美元，複合年成長率為 5.46%。

主要市場統計數據
基準年 2025	45.8億美元
預計年份：2026年	47.8億美元
預測年份 2032	66.5億美元
複合年成長率 (%)	5.46%

神經血管和神經外科醫療設備在現代中風和腦血管疾病的治療中發揮核心作用，其範圍涵蓋機械取栓系統、抽吸導管、血栓摘取支架、血流導引裝置、栓塞彈簧圈、頸動脈支架、神經血管靜脈通路裝置以及具有成像功能的輔助器具。推動這些器械需求的因素包括全球卒中負擔沉重，世界衛生組織（WHO）已將卒中列為導致死亡和長期殘疾的主要原因之一，以及臨床證據表明快速再灌注能夠改善合格的缺血性卒中患者的預後。

醫院間卒中網路、綜合卒中中心的擴張、微創血管內治療以及基於指南的治療路徑正日益影響著這一市場。在醫療器材領域，那些兼具卓越性能、完善的醫生培訓、豐富的真實世界數據、符合監管要求以及工作流程整合優勢的製造商，最有可能在這個競爭激烈的醫療設備領域建立起競爭優勢。

神經血管醫療設備領域的變革性變化

競爭格局正從單一醫療設備轉向整合式卒中治療生態系。醫院優先考慮加快從入院到影像檢查以及從入院到再灌注的流程，這催生了對支持導航、血栓捕獲、血管保護和提高手術效率的醫療設備的需求。臨床趨勢也在發生變化，在某些大血管閉塞病例中，血管內治療的應用越來越廣泛，這得到了大型隨機對照試驗和專業學會指南的支持。

人工智慧（AI）的累積影響

人工智慧（AI）不再是遙遠的概念，它正成為神經血管醫學領域一股實質的驅動力。目前，已獲監管機構批准的AI影像工具正在臨床環境中部署，它們能夠幫助檢測疑似大血管閉塞病例、發出出血警報、進行灌注分析並通知醫療團隊，從而幫助醫院減少診斷延誤，並協調血栓切除術的治療流程。

按地區分類的主要發現

北美憑藉其完善的綜合卒中中心、成熟的急救醫療服務、監管審查流程、臨床試驗基礎設施以及對血管內卒中治療的高度認知，在創新和應用方面始終處於領先地位。歐洲受益於成熟的神經病學網路、CE認證的醫療設備認證流程以及健全的公立醫院體系，但歐盟不斷發展的醫療設備法規越來越重視臨床證據、醫療設備可追溯性和上市後監管。

關鍵群體特定見解

隨著新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國的都市區醫院不斷提升神經介入治療能力，東協市場的重要性日益凸顯，但主要城市以外地區的醫療服務取得仍不均衡。海灣合作理事會（GCC）成員國正加大對三級醫療、數位醫療、急診醫學現代化和專科醫療服務的投資，並成為先進神經血管醫療設備和人工智慧驅動的中風診療流程的主要採用者。

主要國家的概況

美國在血栓切除術的引入、臨床研究、綜合中風中心密度以及人工智慧驅動的中風工作流程應用方面處於主導。加拿大則著重於組織完善的中風系統、公平的醫療服務取得以及實證診療路徑。墨西哥和巴西正透過主要大都會圈的醫院和專科中心擴大中風服務覆蓋範圍，但公立和私立醫療之間的差距仍然是一個重大挑戰。在歐洲，英國、德國、法國、義大利和西班牙擁有由公共醫療系統和介入神經放射學介入技術支援的先進卒中網路，而俄羅斯市場則呈現出區域基礎設施差異、轉診流程複雜以及醫療服務本地化趨勢等特點。

為行業領導者提供的實用建議

產業領導者應優先考慮以同儕審查證據、真實世界臨床註冊數據和可衡量的工作流程結果為支撐的臨床差異化。那些能夠在首次試驗中改善再灌注、減少併發症、便於遠端通路或簡化複雜解剖結構內導航的器械，如果能結合可靠的培訓、模擬支持和上市後檢驗，就能吸引臨床醫生的更多關注。

調查方法

針對神經血管和神經系統醫療設備的嚴謹調查方法應結合以下兩方面：首先，介入神經放射學神經科醫生、血管神經科科醫生、神經外科醫生、急診科醫生、醫院採購經理、監管專家、保險公司和醫療設備公司高管進行初步訪談；其次，應利用同行評審期刊、公開的出版刊物資料庫、臨床指南、衛生監管機構出版物、保險報銷文件、醫院治療路徑以及二次檢驗。

結論

神經血管和神經系統醫療設備市場正在不斷發展，其驅動力包括臨床證據、時間緊迫的卒中治療方案、微創技術的創新以及介入治療的普及。儘管市場應用模式不盡相同，但發展方向明確：醫院和醫療系統正優先採用能夠提高急性複雜神經血管疾病治療速度、安全性、操作一致性和患者預後的技術。

目錄

第1章：序言

第2章：調查方法

• 調查設計
• 研究框架
• 市場規模預測
• 數據三角測量
• 調查結果
• 調查的前提
• 研究限制

第3章執行摘要

• 首席主管觀點
• 市場規模和成長趨勢
• 2025年市佔率分析
• FPNV定位矩陣，2025
• 新的商機
• 下一代經營模式
• 產業藍圖

第4章 市場概覽

• 產業生態系與價值鏈分析
• 市場動態
• 波特五力分析
• PESTLE分析
• 市場展望
• 上市策略

第5章 市場洞察

• 消費者洞察與終端用戶觀點
• 消費者體驗基準
• 機會映射
• 分銷通路分析
• 價格趨勢分析
• 監理合規和標準框架
• ESG與永續性分析
• 中斷和風險情景
• 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：神經血管與神經系統醫療設備市場：依產品分類

• 球囊血管成形術導管
  • 符合規範的氣球
  • 不合規的氣球
• 栓塞線圈
  • 裸露線圈
  • 塗層線圈
  • 水凝膠線圈
• 分流器
  • 可生物分解的導流板
  • 永久性分流器
• 神經血管支架
  • 球囊擴張型支架
  • 自動擴張型支架
• 血栓摘取支架系統
  • 單人紙牌
  • Trevo

第8章：神經血管與神經系統醫療設備市場：依適應症分類

• 動脈瘤閉塞
  • 梭形動脈瘤
  • 囊狀動脈瘤
• 動靜脈畸形
• 出血性中風
• 缺血性中風
  • 預圓筆畫
  • 循環後中風

第9章：神經血管與神經系統醫療設備市場：依技術分類

• 化學溶栓療法
• 流染版
• 機械血栓切除術
  • 吸痰管
  • 血栓摘取支架

第10章：神經血管與神經系統醫療設備市場：依病患年齡層別分類

• 兒童
• 成人
• 老年人

第11章：神經血管與神經系統醫療設備市場：依最終用戶分類

• 門診手術中心
• 醫院
• 專科診所

第12章：神經血管和神經系統醫療設備市場：按地區分類

• 亞太地區
• 北美洲
• 拉丁美洲
• 歐洲
• 中東
• 非洲

第13章：神經血管與神經系統醫療設備市場：依組別分類

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第14章：神經血管和神經系統醫療設備市場：依國家分類

• 美國
• 加拿大
• 墨西哥
• 巴西
• 英國
• 德國
• 法國
• 俄羅斯
• 義大利
• 西班牙
• 中國
• 印度
• 日本
• 澳洲
• 韓國

第15章 競爭格局

• 市場集中度分析，2025年
  • 濃度比（CR）
  • 赫芬達爾-赫希曼指數 (HHI)
• 近期趨勢及影響分析，2025 年
• 2025年產品系列分析
• 基準分析，2025 年

第16章：公司簡介

• Abbott Laboratories
• Acandis GmbH
• AngioDynamics, Inc.
• Asahi Intecc Co., Ltd.
• B. Braun Melsungen AG
• Balt USA, LLC
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cerus Endovascular Ltd.
• Cook Medical LLC
• Endologix LLC
• InspireMD, Inc.
• Integer Holdings Corporation
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson Services, Inc.
• Lepu Medical Technology（Beijing）Co., Ltd.
• Medtronic plc
• Merit Medical Systems, Inc.
• MicroPort Scientific Corporation
• MicroVention, Inc.
• Penumbra, Inc.
• Perflow Medical Ltd.
• Phenox GmbH
• Rapid Medical Ltd.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Spiegelberg GmbH & Co. KG
• Stryker Corporation
• Teleflex Incorporated
• Terumo Corporation
• WL Gore & Associates, Inc.

The Neurovascular Neurology Devices Market is projected to grow by USD 6.65 billion at a CAGR of 5.46% by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 4.58 billion
Estimated Year [2026]	USD 4.78 billion
Forecast Year [2032]	USD 6.65 billion
CAGR (%)	5.46%

Neurovascular neurology devices are central to modern stroke and cerebrovascular care, covering mechanical thrombectomy systems, aspiration catheters, stent retrievers, flow diverters, embolic coils, carotid stents, neurovascular access devices, and adjunctive imaging-enabled tools. Demand is anchored by the global burden of stroke, which the World Health Organization identifies as a leading cause of death and long-term disability, and by clinical evidence showing that rapid reperfusion improves outcomes in eligible ischemic stroke patients.

The market is increasingly shaped by hospital stroke networks, comprehensive stroke center expansion, minimally invasive endovascular procedures, and guideline-supported treatment pathways. Manufacturers that combine device performance, physician training, real-world evidence, regulatory readiness, and workflow integration are best positioned to compete in this high-acuity medical device segment.

Transformative Shifts in the Neurovascular Device Landscape

The competitive landscape is moving from stand-alone devices toward integrated stroke intervention ecosystems. Hospitals are prioritizing faster door-to-imaging and door-to-reperfusion workflows, creating demand for devices that support navigability, clot engagement, vessel preservation, and procedural efficiency. Clinical practice has also shifted toward broader use of endovascular therapy in selected large vessel occlusion cases, supported by major randomized trials and professional society guidelines.

At the same time, reimbursement scrutiny, regulatory evidence expectations, and procurement standardization are raising the bar for adoption. Suppliers must demonstrate safety, efficacy, usability, and economic value across diverse care settings, including hub-and-spoke stroke systems, mobile stroke pathways, and high-volume neurointerventional centers.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a practical accelerator in neurovascular care rather than a distant concept. Regulator-cleared and clinically deployed AI imaging tools already assist with suspected large vessel occlusion detection, hemorrhage alerts, perfusion analysis, and care-team notification, helping hospitals reduce diagnostic delays and coordinate thrombectomy-ready pathways.

The cumulative impact is strongest when AI is linked to validated imaging, secure data exchange, and standardized stroke protocols. For device developers and health systems, AI creates opportunities in procedure planning, patient selection, post-market evidence generation, and training analytics, while also requiring governance around bias, explainability, cybersecurity, interoperability, and clinical accountability.

Key Regional Insights

North America remains a leading innovation and adoption region because of established comprehensive stroke centers, mature emergency medical services, regulatory review pathways, clinical trial infrastructure, and high awareness of endovascular stroke intervention. Europe benefits from mature neurology networks, CE-mark device pathways, and strong public hospital systems, while the European Union's evolving medical device regulation is increasing emphasis on clinical evidence, device traceability, and post-market surveillance.

Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in stroke systems, specialist training, advanced imaging, and neurointerventional capacity. Latin America is improving access through private hospital investment and public stroke initiatives, led by Brazil and Mexico, although access remains concentrated in major urban centers. The Middle East is strengthening tertiary care capacity across Gulf health systems, supported by hospital modernization and digital health programs. Africa remains underpenetrated, with progress tied to CT and angiography availability, trained workforce development, emergency referral networks, and sustained public health investment.

Key Group Insights

ASEAN markets are gaining relevance as urban hospitals in Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines build interventional neurology capability, although access remains uneven outside major cities. GCC countries are investing in tertiary hospitals, digital health, emergency care modernization, and specialist services, making them important adoption hubs for advanced neurovascular devices and AI-enabled stroke workflows.

The European Union supports device uptake through integrated health systems, clinical standardization, cross-border evidence requirements, and stronger post-market surveillance expectations. BRICS countries represent scale opportunities driven by stroke burden, hospital infrastructure expansion, and domestic manufacturing priorities. G7 markets remain central for innovation, reimbursement benchmarks, guideline development, and clinical evidence generation. NATO countries overlap with many high-income markets where emergency care readiness, supply resilience, data protection, and cybersecurity standards increasingly influence procurement and long-term vendor selection.

Key Country Insights

The United States leads in thrombectomy adoption, clinical research, comprehensive stroke center density, and AI-enabled stroke workflow deployment, while Canada emphasizes organized stroke systems, equitable access, and evidence-based care pathways. Mexico and Brazil are expanding access through major metropolitan hospitals and specialist centers, though public-private disparities remain important. In Europe, the United Kingdom, Germany, France, Italy, and Spain have advanced stroke networks supported by public health systems and neurointerventional expertise, while Russia's market is shaped by regional infrastructure variation, referral complexity, and localization dynamics.

China is scaling domestic innovation, hospital capacity, stroke center development, and advanced imaging access, while India offers high long-term clinical need with persistent affordability, infrastructure, and specialist availability challenges. Japan is supported by advanced imaging, aging-population stroke needs, and specialist expertise. Australia benefits from organized stroke pathways, tele-stroke support, and strong tertiary care coordination, while South Korea combines strong hospital infrastructure, medical technology adoption, digital health readiness, and rapid uptake of advanced interventional procedures.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinical differentiation supported by peer-reviewed evidence, real-world registry data, and measurable workflow outcomes. Devices that improve first-pass reperfusion, reduce complications, support distal access, or simplify navigation through complex anatomy can command stronger clinician attention when paired with credible training, simulation support, and post-market validation.

Executives should also build AI-compatible data strategies, strengthen supply chain resilience, and align market access plans with regional reimbursement and procurement realities. Partnerships with stroke networks, imaging providers, hospitals, emergency care teams, and physician educators can accelerate adoption, while localized manufacturing, early regulatory planning, and value-based economic evidence can improve competitiveness in emerging markets.

Research Methodology

A rigorous research methodology for neurovascular neurology devices should combine primary interviews with neurointerventionalists, vascular neurologists, neurosurgeons, emergency physicians, hospital procurement leaders, regulatory experts, payers, and device executives. Secondary validation should draw from peer-reviewed journals, public regulatory databases, clinical guidelines, health authority publications, reimbursement documents, hospital pathway reports, procedure trends, and real-world evidence sources.

Assessment should segment devices by product type, indication, end user, technology, and geography while avoiding unsupported assumptions. Key variables should include stroke incidence and burden, thrombectomy eligibility, imaging availability, trained specialist density, hospital infrastructure, approval timelines, pricing pressure, procurement requirements, safety outcomes, and competitive launches. Triangulation across clinical, commercial, regulatory, and health-system data improves reliability and reduces single-source bias.

Conclusion

The neurovascular neurology devices market is advancing on the strength of clinical evidence, time-sensitive stroke pathways, minimally invasive innovation, and expanding access to interventional care. Adoption is not uniform, but the direction is clear: hospitals and health systems are prioritizing technologies that improve speed, safety, procedural consistency, and patient outcomes in acute and complex neurovascular disease.

The next phase of competition will favor organizations that combine high-performance neurovascular devices with AI-enabled workflows, physician education, real-world evidence, regulatory discipline, and region-specific access strategies. As stroke systems mature worldwide, neurovascular device leaders have a significant opportunity to improve care quality while building durable, evidence-driven positions in the global cerebrovascular care ecosystem.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Neurovascular Neurology Devices Market, by Product

• 7.1. Balloon Angioplasty Catheters
  • 7.1.1. Compliant Balloons
  • 7.1.2. Noncompliant Balloons
• 7.2. Embolic Coils
  • 7.2.1. Bare Coils
  • 7.2.2. Coated Coils
  • 7.2.3. Hydrogel Coils
• 7.3. Flow Diverters
  • 7.3.1. Biodegradable Flow Diverters
  • 7.3.2. Permanent Flow Diverters
• 7.4. Neurovascular Stents
  • 7.4.1. Balloon-Expandable Stents
  • 7.4.2. Self-Expanding Stents
• 7.5. Stent Retriever Systems
  • 7.5.1. Solitaire
  • 7.5.2. Trevo

8. Neurovascular Neurology Devices Market, by Indication

• 8.1. Aneurysm Occlusion
  • 8.1.1. Fusiform Aneurysm
  • 8.1.2. Saccular Aneurysm
• 8.2. Arteriovenous Malformations
• 8.3. Hemorrhagic Stroke
• 8.4. Ischemic Stroke
  • 8.4.1. Anterior Circulation Stroke
  • 8.4.2. Posterior Circulation Stroke

9. Neurovascular Neurology Devices Market, by Technology

• 9.1. Chemical Thrombolysis
• 9.2. Flow Diversion
• 9.3. Mechanical Thrombectomy
  • 9.3.1. Aspiration Catheters
  • 9.3.2. Stent Retrievers

10. Neurovascular Neurology Devices Market, by Patient Age Group

• 10.1. Pediatric
• 10.2. Adult
• 10.3. Geriatric

11. Neurovascular Neurology Devices Market, by End User

• 11.1. Ambulatory Surgical Centers
• 11.2. Hospitals
• 11.3. Specialty Clinics

12. Neurovascular Neurology Devices Market, by Region

• 12.1. Asia-Pacific
• 12.2. North America
• 12.3. Latin America
• 12.4. Europe
• 12.5. Middle East
• 12.6. Africa

13. Neurovascular Neurology Devices Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Neurovascular Neurology Devices Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. Competitive Landscape

• 15.1. Market Concentration Analysis, 2025
  • 15.1.1. Concentration Ratio (CR)
  • 15.1.2. Herfindahl Hirschman Index (HHI)
• 15.2. Recent Developments & Impact Analysis, 2025
• 15.3. Product Portfolio Analysis, 2025
• 15.4. Benchmarking Analysis, 2025

16. Company Profiles

• 16.1. Abbott Laboratories
• 16.2. Acandis GmbH
• 16.3. AngioDynamics, Inc.
• 16.4. Asahi Intecc Co., Ltd.
• 16.5. B. Braun Melsungen AG
• 16.6. Balt USA, LLC
• 16.7. Boston Scientific Corporation
• 16.8. Cardinal Health, Inc.
• 16.9. Cerus Endovascular Ltd.
• 16.10. Cook Medical LLC
• 16.11. Endologix LLC
• 16.12. InspireMD, Inc.
• 16.13. Integer Holdings Corporation
• 16.14. Integra LifeSciences Holdings Corporation
• 16.15. Johnson & Johnson Services, Inc.
• 16.16. Lepu Medical Technology (Beijing) Co., Ltd.
• 16.17. Medtronic plc
• 16.18. Merit Medical Systems, Inc.
• 16.19. MicroPort Scientific Corporation
• 16.20. MicroVention, Inc.
• 16.21. Penumbra, Inc.
• 16.22. Perflow Medical Ltd.
• 16.23. Phenox GmbH
• 16.24. Rapid Medical Ltd.
• 16.25. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 16.26. Spiegelberg GmbH & Co. KG
• 16.27. Stryker Corporation
• 16.28. Teleflex Incorporated
• 16.29. Terumo Corporation
• 16.30. W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
• FIGURE 2. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET, RESEARCH DESIGN
• FIGURE 3. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET, RESEARCH FRAMEWORK
• FIGURE 4. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET, DATA TRIANGULATION
• FIGURE 5. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 6. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 7. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 8. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
• FIGURE 9. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
• FIGURE 11. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
• FIGURE 13. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 14. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
• FIGURE 15. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 16. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
• FIGURE 17. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 18. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
• FIGURE 19. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 20. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
• FIGURE 21. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 22. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
• FIGURE 23. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL BALLOON ANGIOPLASTY CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL BALLOON ANGIOPLASTY CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL BALLOON ANGIOPLASTY CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL COMPLIANT BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL COMPLIANT BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL COMPLIANT BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL NONCOMPLIANT BALLOONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL NONCOMPLIANT BALLOONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL NONCOMPLIANT BALLOONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL EMBOLIC COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL EMBOLIC COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL EMBOLIC COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL BARE COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL BARE COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL BARE COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL COATED COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL COATED COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL COATED COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL HYDROGEL COILS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL HYDROGEL COILS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL HYDROGEL COILS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL FLOW DIVERTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL FLOW DIVERTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL BIODEGRADABLE FLOW DIVERTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL BIODEGRADABLE FLOW DIVERTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL BIODEGRADABLE FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL PERMANENT FLOW DIVERTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL PERMANENT FLOW DIVERTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL PERMANENT FLOW DIVERTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL NEUROVASCULAR STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL STENT RETRIEVER SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL STENT RETRIEVER SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL STENT RETRIEVER SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL SOLITAIRE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL SOLITAIRE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL SOLITAIRE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL TREVO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL TREVO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL TREVO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL ANEURYSM OCCLUSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL ANEURYSM OCCLUSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL ANEURYSM OCCLUSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL FUSIFORM ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL FUSIFORM ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL FUSIFORM ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL SACCULAR ANEURYSM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL SACCULAR ANEURYSM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL SACCULAR ANEURYSM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 62. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 63. GLOBAL ARTERIOVENOUS MALFORMATIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 64. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 65. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 66. GLOBAL HEMORRHAGIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 67. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 68. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 69. GLOBAL ISCHEMIC STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 70. GLOBAL ANTERIOR CIRCULATION STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 71. GLOBAL ANTERIOR CIRCULATION STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 72. GLOBAL ANTERIOR CIRCULATION STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 73. GLOBAL POSTERIOR CIRCULATION STROKE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 74. GLOBAL POSTERIOR CIRCULATION STROKE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 75. GLOBAL POSTERIOR CIRCULATION STROKE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 76. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 77. GLOBAL CHEMICAL THROMBOLYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 78. GLOBAL CHEMICAL THROMBOLYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 79. GLOBAL CHEMICAL THROMBOLYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 80. GLOBAL FLOW DIVERSION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 81. GLOBAL FLOW DIVERSION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 82. GLOBAL FLOW DIVERSION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 83. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 84. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 85. GLOBAL MECHANICAL THROMBECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 86. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 87. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 88. GLOBAL ASPIRATION CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 89. GLOBAL STENT RETRIEVERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 90. GLOBAL STENT RETRIEVERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 91. GLOBAL STENT RETRIEVERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 92. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 93. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 94. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 95. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 96. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 97. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 98. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 99. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 100. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 101. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 102. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 103. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 104. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 105. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 106. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 107. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 108. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 109. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 110. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 111. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 112. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 113. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 114. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 115. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 116. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 117. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 118. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 119. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 120. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 121. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 122. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 123. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 124. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 125. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 126. ASIA-PACIFIC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 127. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 128. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 129. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 130. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 131. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 132. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 133. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 134. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 135. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 136. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 137. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 138. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 139. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 140. NORTH AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 141. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 142. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 143. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 144. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 145. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 146. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 147. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 148. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 149. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 150. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 151. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 152. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 153. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 154. LATIN AMERICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 155. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 156. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 157. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 158. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 159. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 160. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 161. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 162. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 163. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 164. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 165. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 166. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 167. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 168. EUROPE NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 169. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 170. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 171. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 172. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 173. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 174. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 175. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 176. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 177. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 178. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 179. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 180. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 181. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 182. MIDDLE EAST NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 183. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 184. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 185. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 186. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 187. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 188. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 189. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 190. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 191. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 192. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 193. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 194. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 195. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 196. AFRICA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 197. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 198. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 199. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 200. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 201. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 202. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 203. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 204. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 205. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 206. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 207. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 208. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 209. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 210. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 211. ASEAN NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 212. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 213. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 214. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 215. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 216. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 217. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 218. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 219. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 220. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 221. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 222. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 223. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 224. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 225. GCC NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 226. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 227. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 228. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 229. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 230. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 231. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 232. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 233. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 234. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 235. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 236. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 237. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 238. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 239. EUROPEAN UNION NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 240. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 241. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 242. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 243. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 244. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 245. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 246. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 247. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 248. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 249. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 250. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 251. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 252. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 253. BRICS NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 254. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 255. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 256. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 257. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 258. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 259. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 260. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 261. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 262. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 263. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 264. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 265. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 266. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 267. G7 NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 268. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 269. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 270. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 271. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 272. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 273. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 274. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 275. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 276. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 277. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 278. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 279. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 280. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 281. NATO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 282. GLOBAL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 283. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 284. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 285. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 286. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 287. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 288. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 289. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 290. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 291. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 292. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 293. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 294. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 295. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 296. UNITED STATES NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 297. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 298. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 299. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 300. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 301. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 302. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 303. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 304. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 305. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 306. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 307. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 308. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 309. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 310. CANADA NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 311. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 312. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 313. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 314. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY EMBOLIC COILS, 2018-2032 (USD MILLION)
• TABLE 315. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY FLOW DIVERTERS, 2018-2032 (USD MILLION)
• TABLE 316. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY NEUROVASCULAR STENTS, 2018-2032 (USD MILLION)
• TABLE 317. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY STENT RETRIEVER SYSTEMS, 2018-2032 (USD MILLION)
• TABLE 318. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
• TABLE 319. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ANEURYSM OCCLUSION, 2018-2032 (USD MILLION)
• TABLE 320. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY ISCHEMIC STROKE, 2018-2032 (USD MILLION)
• TABLE 321. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
• TABLE 322. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY MECHANICAL THROMBECTOMY, 2018-2032 (USD MILLION)
• TABLE 323. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
• TABLE 324. MEXICO NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 325. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 326. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
• TABLE 327. BRAZIL NEUROVASCULAR NEUROLOGY DEVICES MARKET SIZE, BY BALLOON ANGIOPLASTY CATHETERS, 2018-2032 (USD MILLION)
• TABLE 328. BR